IL161673A0 - Compositions and methods for therapy of chemotherapy-induced neuropathy - Google Patents
Compositions and methods for therapy of chemotherapy-induced neuropathyInfo
- Publication number
- IL161673A0 IL161673A0 IL16167304A IL16167304A IL161673A0 IL 161673 A0 IL161673 A0 IL 161673A0 IL 16167304 A IL16167304 A IL 16167304A IL 16167304 A IL16167304 A IL 16167304A IL 161673 A0 IL161673 A0 IL 161673A0
- Authority
- IL
- Israel
- Prior art keywords
- chemotherapy
- therapy
- compositions
- methods
- induced neuropathy
- Prior art date
Links
- 238000002512 chemotherapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 201000001119 neuropathy Diseases 0.000 title 1
- 230000007823 neuropathy Effects 0.000 title 1
- 208000033808 peripheral neuropathy Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16167304A IL161673A0 (en) | 2004-04-29 | 2004-04-29 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
ES05737409.2T ES2657049T3 (es) | 2004-04-29 | 2005-04-28 | IL-6 para la terapia o prevención de neuropatías inducidas por quimioterapia |
EP16188978.7A EP3124040B1 (fr) | 2004-04-29 | 2005-04-28 | Il-6 pour le traitement d'une neuropathie induite par une chimiotherapie |
DK16188978.7T DK3124040T3 (da) | 2004-04-29 | 2005-04-28 | Il-6 til terapi af kemoterapi-induceret neuropati |
DK05737409.2T DK1740200T3 (en) | 2004-04-29 | 2005-04-28 | IL-6 FOR THERAPY OR PREVENTION OF CHEMOTHERAPY-INDUCED NEUROPATHY |
AU2005237324A AU2005237324A1 (en) | 2004-04-29 | 2005-04-28 | IL-6 for therapy or prevention of chemotherapy-induced neuropathy |
PL05737409T PL1740200T3 (pl) | 2004-04-29 | 2005-04-28 | IL-6 do terapii lub zapobiegania neuropatii wywołanej chemioterapią |
EP05737409.2A EP1740200B1 (fr) | 2004-04-29 | 2005-04-28 | Il-6 pour traitement ou prevention d'une neuropathie induite par une chimiotherapie |
US11/587,937 US7951359B2 (en) | 2004-04-29 | 2005-04-28 | Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy |
JP2007510235A JP2007534746A (ja) | 2004-04-29 | 2005-04-28 | 化学療法誘発性ニューロパシーの治療または予防のためのil−6 |
CA002564390A CA2564390A1 (fr) | 2004-04-29 | 2005-04-28 | Il-6 pour traitement ou prevention d'une neuropathie induite par une chimiotherapie |
PL16188978T PL3124040T3 (pl) | 2004-04-29 | 2005-04-28 | IL-6 do terapii lub zapobiegania neuropatii wywołanej chemioterapią |
PCT/IL2005/000444 WO2005105135A1 (fr) | 2004-04-29 | 2005-04-28 | Il-6 pour traitement ou prevention d'une neuropathie induite par une chimiotherapie |
ES16188978T ES2788131T3 (es) | 2004-04-29 | 2005-04-28 | IL-6 para la terapia de neuropatías inducidas por quimioterapia |
IL178636A IL178636A0 (en) | 2004-04-29 | 2006-10-16 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
NO20065471A NO20065471L (no) | 2004-04-29 | 2006-11-28 | Anvendelse av IL-6 for behandling eller forebygging av kjemoterapiindusert nevropati. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16167304A IL161673A0 (en) | 2004-04-29 | 2004-04-29 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161673A0 true IL161673A0 (en) | 2004-09-27 |
Family
ID=34074041
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16167304A IL161673A0 (en) | 2004-04-29 | 2004-04-29 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
IL178636A IL178636A0 (en) | 2004-04-29 | 2006-10-16 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL178636A IL178636A0 (en) | 2004-04-29 | 2006-10-16 | Compositions and methods for therapy of chemotherapy-induced neuropathy |
Country Status (11)
Country | Link |
---|---|
US (1) | US7951359B2 (fr) |
EP (2) | EP3124040B1 (fr) |
JP (1) | JP2007534746A (fr) |
AU (1) | AU2005237324A1 (fr) |
CA (1) | CA2564390A1 (fr) |
DK (2) | DK1740200T3 (fr) |
ES (2) | ES2788131T3 (fr) |
IL (2) | IL161673A0 (fr) |
NO (1) | NO20065471L (fr) |
PL (2) | PL1740200T3 (fr) |
WO (1) | WO2005105135A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533642A (zh) * | 2018-05-17 | 2021-03-19 | 赫利世弥斯株式会社 | 治疗与化疗诱发的周围神经病变相关的神经性疼痛 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL163856A0 (en) | 2004-09-01 | 2005-12-18 | Applied Research Systems | Use of IL-6 in vascular complications |
WO2009069133A2 (fr) | 2007-11-28 | 2009-06-04 | Hadasit Medical Research Services And Development Ltd. | Procédés de traitement de lésion tissulaire induite par un rayonnement ou une chimiothérapie |
US20130230580A1 (en) * | 2010-09-14 | 2013-09-05 | Paul S. Frenette | Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration |
EP3299032A1 (fr) | 2016-09-23 | 2018-03-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Inhibiteurs de gpr132 destinés à être utilisés dans la prévention et/ou le traitement de la douleur neuropathique induite par chimiothérapie |
WO2022256688A1 (fr) * | 2021-06-04 | 2022-12-08 | Sonnet BioTherapeutics, Inc. | Méthodes de traitement de la fragilité liée à l'âge avec de l'interleukine-6 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4588585A (en) | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
US4959314A (en) | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
US5116943A (en) | 1985-01-18 | 1992-05-26 | Cetus Corporation | Oxidation-resistant muteins of Il-2 and other protein |
US5017691A (en) | 1986-07-03 | 1991-05-21 | Schering Corporation | Mammalian interleukin-4 |
US4879111A (en) | 1986-04-17 | 1989-11-07 | Cetus Corporation | Treatment of infections with lymphokines |
US4965195A (en) | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
US4904584A (en) | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
DK0779362T4 (da) | 1989-12-22 | 2012-07-30 | Serono Lab | DNA-konstruktioner til aktivering og modifikation af endogene geners ekspression |
DE69230789T3 (de) | 1991-01-18 | 2007-10-31 | Amgen Inc., Thousand Oaks | Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten |
IT1247484B (it) | 1991-03-22 | 1994-12-17 | Ceinge Societa Consortile A R | Metodo per la preparazione di interleuchina 6 |
WO1994003492A1 (fr) | 1992-08-06 | 1994-02-17 | The University Of Melbourne | Variantes de l'interleukine-6 et leurs utilisations |
IT1263022B (it) | 1992-11-06 | 1996-07-23 | Angeletti P Ist Richerche Bio | Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica. |
IT1261787B (it) | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
US5635599A (en) | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
WO1997016202A1 (fr) * | 1995-10-27 | 1997-05-09 | Amrad Operations Pty. Ltd. | Cytokines et leur utilisation dans le traitement et/ou la prophylaxie du cancer du sein |
ES2312177T3 (es) * | 1996-05-22 | 2009-02-16 | Viventia Biotech Inc. | Fragmentos de union a antigenos que detectan especificamente celulas cancerosas, nucleotidos que codifican los fragmentos y el uso de los mismos para la profilaxis y deteccion de canceres. |
DE69830305T2 (de) * | 1997-02-20 | 2006-02-02 | Dime, David S., Toronto | Ortsspezifische arzneimittel verabreichung |
IT1291932B1 (it) * | 1997-06-20 | 1999-01-21 | Angeletti P Ist Richerche Bio | Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma |
IL122818A0 (en) | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
CA2379388C (fr) | 1999-07-13 | 2012-05-29 | George N. Cox, Iii | Proteines de fusion d'immunoglobine |
IL161310A0 (en) * | 2001-10-11 | 2004-09-27 | Applied Research Systems | Use of a substance signaling through gp 130 in pns disorders |
IL163856A0 (en) * | 2004-09-01 | 2005-12-18 | Applied Research Systems | Use of IL-6 in vascular complications |
-
2004
- 2004-04-29 IL IL16167304A patent/IL161673A0/xx unknown
-
2005
- 2005-04-28 AU AU2005237324A patent/AU2005237324A1/en not_active Abandoned
- 2005-04-28 PL PL05737409T patent/PL1740200T3/pl unknown
- 2005-04-28 WO PCT/IL2005/000444 patent/WO2005105135A1/fr active Application Filing
- 2005-04-28 PL PL16188978T patent/PL3124040T3/pl unknown
- 2005-04-28 JP JP2007510235A patent/JP2007534746A/ja active Pending
- 2005-04-28 DK DK05737409.2T patent/DK1740200T3/en active
- 2005-04-28 US US11/587,937 patent/US7951359B2/en active Active
- 2005-04-28 CA CA002564390A patent/CA2564390A1/fr not_active Abandoned
- 2005-04-28 EP EP16188978.7A patent/EP3124040B1/fr active Active
- 2005-04-28 EP EP05737409.2A patent/EP1740200B1/fr active Active
- 2005-04-28 ES ES16188978T patent/ES2788131T3/es active Active
- 2005-04-28 DK DK16188978.7T patent/DK3124040T3/da active
- 2005-04-28 ES ES05737409.2T patent/ES2657049T3/es active Active
-
2006
- 2006-10-16 IL IL178636A patent/IL178636A0/en unknown
- 2006-11-28 NO NO20065471A patent/NO20065471L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533642A (zh) * | 2018-05-17 | 2021-03-19 | 赫利世弥斯株式会社 | 治疗与化疗诱发的周围神经病变相关的神经性疼痛 |
Also Published As
Publication number | Publication date |
---|---|
DK1740200T3 (en) | 2018-01-08 |
PL1740200T3 (pl) | 2018-04-30 |
US20080193409A1 (en) | 2008-08-14 |
EP3124040A1 (fr) | 2017-02-01 |
US7951359B2 (en) | 2011-05-31 |
JP2007534746A (ja) | 2007-11-29 |
WO2005105135A1 (fr) | 2005-11-10 |
ES2657049T3 (es) | 2018-03-01 |
CA2564390A1 (fr) | 2005-11-10 |
NO20065471L (no) | 2007-01-09 |
PL3124040T3 (pl) | 2020-08-24 |
EP3124040B1 (fr) | 2020-02-12 |
IL178636A0 (en) | 2007-02-11 |
EP1740200B1 (fr) | 2017-11-22 |
DK3124040T3 (da) | 2020-04-20 |
AU2005237324A1 (en) | 2005-11-10 |
EP1740200A1 (fr) | 2007-01-10 |
ES2788131T3 (es) | 2020-10-20 |
WO2005105135A8 (fr) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1737482A4 (fr) | Compositions et methodes de traitement de maladies | |
HK1110602A1 (en) | Compositions and methods of using angiopoietin-like protein | |
IL184047A0 (en) | Methods and compositions for treating amyloid-related diseases | |
EP1804832A4 (fr) | Méthodes et compositions pour apport sans aiguille de macromolécules | |
EP1718331A4 (fr) | Procedes et compositions pour le dosage d'allergenes | |
EP1933862A4 (fr) | Procedes et compositions pour l'administration orale de proteines | |
IL189364A0 (en) | Estrogen compositions and therapeutic methods of use thereof | |
EP1966246A4 (fr) | Procédés et compositions servant à l'apport, sans aiguille, d'anticorps | |
EP1812031A4 (fr) | Compositions et procedes de modification de biomolecules | |
IL191072A0 (en) | Therapeutic compositions and methods | |
IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
ZA200704768B (en) | Stabilized ramipril compositions and methods of making | |
EP1763358A4 (fr) | Compositions et methodes coupe-faim | |
IL179931A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
IL183709A0 (en) | Compositions and methods for treating conditions of the nail unit | |
IL182943A0 (en) | Ovr110 antibody compositions and methods of use | |
ZA200705297B (en) | Methods and compositions for treating amyloid related diseases | |
EP1786265A4 (fr) | Nouvelles compositions et procedes de traitement | |
IL186325A0 (en) | Tizanidine compositions and methods of treatment using the compositions | |
EP1720563A4 (fr) | Procedes et compositions de traitement de l'inflammation | |
HK1109576A1 (en) | Aequorin-containing compositions and methods of using same | |
IL178636A0 (en) | Compositions and methods for therapy of chemotherapy-induced neuropathy | |
GB0608398D0 (en) | Pharmaceutical composition and method of using same | |
EP1773349A4 (fr) | Methodes et compositions de traitement de la preeclampsie | |
IL178635A0 (en) | Compositions and methods for therapy of chemotherapy-induced neuropathy |